NLRP1 and melanoma: Next, to evaluate the relationship between the increased NLRP1/3 expression and activated inflammasomes observed in Figure 2, we silenced NLRP1 or NLRP3 in melanoma cells using small interfering RNAs (siRNAs) and treated the cells with 100 μM TMZ for 48 h (Figure 3A).